A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

Background: Current PSA-based tests used to detect prostate cancer (PCa) lack sufficient specificity, leading to significant overdetection and overtreatment. Our previous studies showed that serum fucosylated PSA (Fuc-PSA) and soluble TEK receptor tyrosine kinase (Tie-2) had the ability to predict a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Song, Jin, Ma, Shiyong, Sokoll, Lori J., Eguez, Rodrigo V., Höti, Naseruddin, Zhang, Hui, Mohr, Phaedre, Dua, Renu, Patil, Dattatraya, May, Kristen Douglas, Williams, Sierra, Arnold, Rebecca, Sanda, Martin G., Chan, Daniel W., Zhang, Zhen
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120218/
https://ncbi.nlm.nih.gov/pubmed/33995654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.55676
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados